121 related articles for article (PubMed ID: 23751563)
1. Ischemia modified albumin and plasma oxidative stress markers in Alzheimer's disease.
Can M; Varlibas F; Guven B; Akhan O; Yuksel GA
Eur Neurol; 2013; 69(6):377-80. PubMed ID: 23751563
[TBL] [Abstract][Full Text] [Related]
2. Decreased plasma antioxidants in patients with Alzheimer's disease.
Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
[TBL] [Abstract][Full Text] [Related]
3. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome.
Simão AN; Dichi JB; Barbosa DS; Cecchini R; Dichi I
Nutrition; 2008; 24(7-8):675-81. PubMed ID: 18499396
[TBL] [Abstract][Full Text] [Related]
4. Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's disease.
Yavuz BB; Yavuz B; Halil M; Cankurtaran M; Ulger Z; Cankurtaran ES; Aytemir K; Ariogul S
Int Psychogeriatr; 2008 Aug; 20(4):815-23. PubMed ID: 18416873
[TBL] [Abstract][Full Text] [Related]
5. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
[TBL] [Abstract][Full Text] [Related]
6. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
[TBL] [Abstract][Full Text] [Related]
7. Altered levels of homocysteine and serum natural antioxidants links oxidative damage to Alzheimer's disease.
Cankurtaran M; Yesil Y; Kuyumcu ME; Oztürk ZA; Yavuz BB; Halil M; Ulger Z; Cankurtaran ES; Arıoğul S
J Alzheimers Dis; 2013; 33(4):1051-8. PubMed ID: 23109556
[TBL] [Abstract][Full Text] [Related]
8. Relation between uric acid and Alzheimer's disease in elderly Jordanians.
Al-khateeb E; Althaher A; Al-khateeb M; Al-Musawi H; Azzouqah O; Al-Shweiki S; Shafagoj Y
J Alzheimers Dis; 2015; 44(3):859-65. PubMed ID: 25362039
[TBL] [Abstract][Full Text] [Related]
9. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
[TBL] [Abstract][Full Text] [Related]
11. Ischemia modified albumin: an oxidative stress marker in β-thalassemia major.
Awadallah SM; Atoum MF; Nimer NA; Saleh SA
Clin Chim Acta; 2012 May; 413(9-10):907-10. PubMed ID: 22336636
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
[TBL] [Abstract][Full Text] [Related]
13. Obesity is an independent determinant of ischemia-modified albumin.
Mehmetoğlu I; Kurban S; Yerlikaya FH; Polat H
Obes Facts; 2012; 5(5):700-9. PubMed ID: 23108391
[TBL] [Abstract][Full Text] [Related]
14. Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.
Keshavarzi F; Rastegar M; Vessal M; Rafiei Dehbidi G; Khorsand M; Ganjkarimi AH; Takhshid MA
Metab Brain Dis; 2018 Jun; 33(3):675-680. PubMed ID: 29270710
[TBL] [Abstract][Full Text] [Related]
15. Assessment of ischaemia-modified albumin level in patients with psoriasis.
Ozdemir M; Kiyici A; Balevi A; Mevlitoğlu I; Peru C
Clin Exp Dermatol; 2012 Aug; 37(6):610-4. PubMed ID: 22607558
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus.
Kurban S; Mehmetoglu I; Yerlikaya HF; Gönen S; Erdem S
Endocr Res; 2011; 36(3):116-23. PubMed ID: 21736494
[TBL] [Abstract][Full Text] [Related]
17. Ischemia-modified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation.
Zuwała-Jagiełło J; Warwas M; Pazgan-Simon M
Acta Biochim Pol; 2012; 59(4):661-7. PubMed ID: 23227456
[TBL] [Abstract][Full Text] [Related]
18. The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies.
Guven S; Alver A; Mentese A; Ilhan FC; Calapoglu M; Unsal MA
Acta Obstet Gynecol Scand; 2009; 88(4):479-82. PubMed ID: 19235558
[TBL] [Abstract][Full Text] [Related]
19. Infrared spectroscopy: a reagent-free method to distinguish Alzheimer's disease patients from normal-aging subjects.
Peuchant E; Richard-Harston S; Bourdel-Marchasson I; Dartigues JF; Letenneur L; Barberger-Gateau P; Arnaud-Dabernat S; Daniel JY
Transl Res; 2008 Sep; 152(3):103-12. PubMed ID: 18774539
[TBL] [Abstract][Full Text] [Related]
20. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
